[SCHEDULE 13G/A] Eastman Chemical Company SEC Filing

Rhea-AI Filing Summary

Capital Research Global Investors filed a Schedule 13G/A reporting beneficial ownership of 4,246,293 shares of Eastman Chemical Company common stock, representing 3.7% of the 115,459,908 shares believed outstanding. The filing lists the holder as Capital Research Global Investors, a division of Capital Research and Management Company, and provides issuer and filer addresses.

The filing certifies the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. The document is signed by Jae Won Chung on behalf of Capital Research Global Investors with a signature date of 08/05/2025.

Insights

Securities Analyst

TL;DR: Passive institutional stake of 3.7% in EMN; routine disclosure under Schedule 13G/A, not a control-seeking filing.

This Schedule 13G/A reports an institutional ownership position of 4,246,293 shares (3.7%) in Eastman Chemical (EMN). The filer expressly certifies the position is held in the ordinary course of business and not to influence control, consistent with a passive investor filing under Rule 13d-1(c). Given the ownership is below 5%, this is a routine disclosure and is unlikely to be material to corporate control or near-term valuation.

Corporate Governance Expert

TL;DR: Filing demonstrates compliance and passive intent; no governance change signaled.

The amendment (Schedule 13G/A) includes the required certification that the securities were not acquired to change or influence control. The reporting person is identified and the filing includes required voting and dispositive power details showing sole voting and dispositive power over 4,246,293 shares. From a governance perspective, this filing documents a passive institutional holding and does not indicate activist or control intent.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Eastman Chemical Co.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

277432100

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 277432100

1

Names of Reporting Persons

Capital Research Global Investors

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 4,246,293.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 4,246,293.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,246,293.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.7 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Eastman Chemical Co.
(b)	Address of issuer's principal executive offices: 200 South Wilcox Drive, Kingsport, TN 37660, United States of America
Item 2.
(a)	Name of person filing: Capital Research Global Investors
(b)	Address or principal business office or, if none, residence: 333 South Hope Street, 55th Fl, Los Angeles, CA 90071
(c)	Citizenship: N/A
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 277432100
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 4,246,293 ** **Capital Research Global Investors ("CRGI") is a division of Capital Research and Management Company ("CRMC"), as well as its investment management subsidiaries and affiliates Capital Bank and Trust Company, Capital International, Inc., Capital International Limited, Capital International Sarl, Capital International K.K., Capital Group Private Client Services, Inc., and Capital Group Investment Management Private Limited (together with CRMC, the "investment management entities"). CRGI's divisions of each of the investment management entities collectively provide investment management services under the name "Capital Research Global Investors." CRGI is deemed to be the beneficial owner of 4,246,293 shares or 3.7% of the 115,459,908 shares believed to be outstanding.
(b)	Percent of class: 3.7 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 4,246,293
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 4,246,293
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Capital Research Global Investors

Signature:	Jae Won Chung
Name/Title:	Vice President and Senior Counsel II, Capital Research and Management Company
Date:	08/05/2025

FAQ

What stake does Capital Research Global Investors report in Eastman Chemical (EMN)?

The filing reports 4,246,293 shares, representing 3.7% of Eastman Chemical's common stock.

Was the 13G/A filing for EMN filed as a passive ownership report or for control purposes?

The filer certified the securities were acquired and are held in the ordinary course of business and not to change or influence control, indicating a passive Schedule 13G/A filing.

Who filed the Schedule 13G/A for EMN and where is the filer located?

The filer is Capital Research Global Investors, part of Capital Research and Management Company, with an address at 333 South Hope Street, 55th Fl, Los Angeles, CA 90071.

What voting and dispositive power does the filer report for EMN shares?

The filer reports sole voting power of 4,246,293 shares and sole dispositive power of 4,246,293 shares; no shared voting or dispositive power is reported.

When was the Schedule 13G/A for Eastman (EMN) signed?

The filing is signed by Jae Won Chung on behalf of Capital Research Global Investors with a signature date of 08/05/2025.